Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.

<h4>Introduction</h4>Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% coverage of persons with CD4<350 cells/µl by 2009-10. We explored impact on mortality and HIV prevalence, analyzing surveillance and civil registration data.<h4...

Full description

Saved in:
Bibliographic Details
Main Authors: Rand Stoneburner, Eline Korenromp, Mark Lazenby, Jean-Michel Tassie, Judith Letebele, Diemo Motlapele, Reuben Granich, Ties Boerma, Daniel Low-Beer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0100431
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849726500186619904
author Rand Stoneburner
Eline Korenromp
Mark Lazenby
Jean-Michel Tassie
Judith Letebele
Diemo Motlapele
Reuben Granich
Ties Boerma
Daniel Low-Beer
author_facet Rand Stoneburner
Eline Korenromp
Mark Lazenby
Jean-Michel Tassie
Judith Letebele
Diemo Motlapele
Reuben Granich
Ties Boerma
Daniel Low-Beer
author_sort Rand Stoneburner
collection DOAJ
description <h4>Introduction</h4>Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% coverage of persons with CD4<350 cells/µl by 2009-10. We explored impact on mortality and HIV prevalence, analyzing surveillance and civil registration data.<h4>Methods</h4>Hospital natural cause admissions and deaths from the Health Statistics Unit (HSU) over 1990-2009, all-cause deaths from Midnight Bed Census (MNC) over 1990-2011, institutional and non-institutional deaths recorded in the Registry of Birth and Deaths (RBD) over 2003-2010, and antenatal sentinel surveillance (ANC) over 1992-2011 were compared to numbers of persons receiving ART. Mortality was adjusted for differential coverage and completeness of institutional and non-institutional deaths, and compared to WHO and UNAIDS Spectrum projections.<h4>Results</h4>HSU deaths per 1000 admissions declined 49% in adults 15-64 years over 2003-2009. RBD mortality declined 44% (807 to 452/100,000 population in adults 15-64 years) over 2003-2010, similarly in males and females. Generally, death rates were higher in males; declines were greater and earlier in younger adults, and in females. In contrast, death rates in adults 65+, particularly females increased over 2003-2006. MNC all-age post-neonatal mortality declined 46% and 63% in primary and secondary level hospitals, over 2003-2011. We estimated RBD captured 80% of adult deaths over 2006-2011. Comparing empirical, completeness-adjusted deaths to Spectrum estimates, declines over 2003-2009 were similar overall (47% vs. 54%); however, Spectrum projected larger and earlier declines particularly in women. Following stabilization and modest decreases over 1998-2002, HIV prevalence in pregnant women 15-24 and 25-29-years declined by >50% and >30% through 2011, while continuing to increase in older women.<h4>Conclusions</h4>Adult mortality in Botswana fell markedly as ART coverage increased. HIV prevalence declines may reflect ART-associated reductions in sexual transmission. Triangulation of surveillance system data offers a reasonable approach to evaluate impact of HIV/AIDS interventions, complementing cohort approaches that monitor individual-level health outcomes.
format Article
id doaj-art-eb1d7fb074d14b6cb11cf9787c8828aa
institution DOAJ
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-eb1d7fb074d14b6cb11cf9787c8828aa2025-08-20T03:10:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0197e10043110.1371/journal.pone.0100431Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.Rand StoneburnerEline KorenrompMark LazenbyJean-Michel TassieJudith LetebeleDiemo MotlapeleReuben GranichTies BoermaDaniel Low-Beer<h4>Introduction</h4>Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% coverage of persons with CD4<350 cells/µl by 2009-10. We explored impact on mortality and HIV prevalence, analyzing surveillance and civil registration data.<h4>Methods</h4>Hospital natural cause admissions and deaths from the Health Statistics Unit (HSU) over 1990-2009, all-cause deaths from Midnight Bed Census (MNC) over 1990-2011, institutional and non-institutional deaths recorded in the Registry of Birth and Deaths (RBD) over 2003-2010, and antenatal sentinel surveillance (ANC) over 1992-2011 were compared to numbers of persons receiving ART. Mortality was adjusted for differential coverage and completeness of institutional and non-institutional deaths, and compared to WHO and UNAIDS Spectrum projections.<h4>Results</h4>HSU deaths per 1000 admissions declined 49% in adults 15-64 years over 2003-2009. RBD mortality declined 44% (807 to 452/100,000 population in adults 15-64 years) over 2003-2010, similarly in males and females. Generally, death rates were higher in males; declines were greater and earlier in younger adults, and in females. In contrast, death rates in adults 65+, particularly females increased over 2003-2006. MNC all-age post-neonatal mortality declined 46% and 63% in primary and secondary level hospitals, over 2003-2011. We estimated RBD captured 80% of adult deaths over 2006-2011. Comparing empirical, completeness-adjusted deaths to Spectrum estimates, declines over 2003-2009 were similar overall (47% vs. 54%); however, Spectrum projected larger and earlier declines particularly in women. Following stabilization and modest decreases over 1998-2002, HIV prevalence in pregnant women 15-24 and 25-29-years declined by >50% and >30% through 2011, while continuing to increase in older women.<h4>Conclusions</h4>Adult mortality in Botswana fell markedly as ART coverage increased. HIV prevalence declines may reflect ART-associated reductions in sexual transmission. Triangulation of surveillance system data offers a reasonable approach to evaluate impact of HIV/AIDS interventions, complementing cohort approaches that monitor individual-level health outcomes.https://doi.org/10.1371/journal.pone.0100431
spellingShingle Rand Stoneburner
Eline Korenromp
Mark Lazenby
Jean-Michel Tassie
Judith Letebele
Diemo Motlapele
Reuben Granich
Ties Boerma
Daniel Low-Beer
Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.
PLoS ONE
title Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.
title_full Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.
title_fullStr Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.
title_full_unstemmed Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.
title_short Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana.
title_sort using health surveillance systems data to assess the impact of aids and antiretroviral treatment on adult morbidity and mortality in botswana
url https://doi.org/10.1371/journal.pone.0100431
work_keys_str_mv AT randstoneburner usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana
AT elinekorenromp usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana
AT marklazenby usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana
AT jeanmicheltassie usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana
AT judithletebele usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana
AT diemomotlapele usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana
AT reubengranich usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana
AT tiesboerma usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana
AT daniellowbeer usinghealthsurveillancesystemsdatatoassesstheimpactofaidsandantiretroviraltreatmentonadultmorbidityandmortalityinbotswana